Citation APA
Leleu, X., Attal, M., Arnulf, B., Moreau, P., Traulle, C., Marit, G., Mathiot, C., Petillon, M. O., Macro, M., Roussel, M., Pegourie, B., Kolb, B., Stoppa, A. M., Hennache, B., Bréchignac, S., Meuleman, N., Thielemans, B., Garderet, L., Royer, B., Hulin, C., Benboubker, L., Decaux, O., Escoffre-Barbe, M., Michallet, M., Caillot, D., Fermand, J.-P., Avet-Loiseau, H., Facon, T., & Intergroupe Francophone du Myélome, (2013). Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02. Blood, 121(11), 1968-1975. doi:10.1182/blood-2012-09-452375
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/200242